On April 22, Wu Shu, Director of Anqing Science and Technology Bureau and Secretary of the Party committees of the bureau, visited CHICO Pharma's R & D center in Nanjing for survey. He investigated our work on the Industry-University-Research cooperation, put forward valuable opinions and suggestions.
The R & D center is located in building F7, Jiangsu life science and Technology Innovation Park, No. 9, Weidi Road, Xianlin University Town, Qixia District, Nanjing, with a building area of 1800 square meters. In 2019, it was approved as the "national high-tech enterprise". It specializes in the research and development of characteristic pharmaceutical APIs and high-end pharmaceutical intermediates, such as anti-tumor drugs, anti-diabetic drugs, anti-viral drugs, anti cardiovascular-drugs and so on.
The Company has established Industry-University-Research cooperative relations with the analysis and testing center of Nanjing Normal University in the way of "co-construction, sharing and win-win". Besides Nanjing Normal University, it also has established cooperative relations with other universities, such as Changzhou technology Institute, Nanjing technology University and so on.
